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We are in the grip of a smoking epidemic: an estimated 
106,000 people in the UK are dying needlessly each year 
because of smoking.  This smoking epidemic is also a root 
cause of health inequality – numbers of deaths are higher in 
disadvantaged areas.
 
I welcome the publication of The smoking epidemic in 
England which starkly sets out the scale of the problem we 
face.  The report presents the latest estimates of deaths 
caused by cigarette smoking in England and the UK.  For 
the fi rst time, it presents the estimated fi gures of smoking–
attributable deaths in each primary care trust (PCT) across 
England.  Signifi cant health inequalities are revealed with the 
percentage of deaths caused by smoking varying by around 
20% across primary care trusts.  
 
Although the number of deaths caused by smoking refl ects 
past smoking behaviour, the fi ndings from this report 
suggest that these alarming variations will continue for some 
time.  As the researchers note, these fi gures will almost 
certainly underestimate the impact of smoking, as they do 
not take account of the number of deaths caused by second-
hand smoke.  
 
Smoking isn’t just a national problem; these fi gures show 
clearly how our local communities are affected.  We’re 
making progress with smoking cessation programmes, but 
we still have a long way to go.  I believe that this report will 
be a valuable tool to help primary care trusts make the case 
for smoking cessation resources in their area, and a useful 
document for everyone working to tackle the prevalence of 
smoking in this country.
Sir Liam Donaldson
Chief Medical Offi cer
Department of Health
Foreword
1Summary
This report summarises research commissioned by the Health 
Development Agency and undertaken by the Institute for the 
Geography of Health, University of Portsmouth. The main 
objective of the study was to estimate levels of smoking-
attributable mortality across two target geographies: primary 
care trusts (PCTs) and strategic health authorities (SHAs) in 
England.
Estimates of smoking-attributable deaths are based on 
data from three sources: published relative risk factors for 
mortality of current and ex-smokers from various diseases; 
small-area counts of death by cause in England for the period 
1998–2002; and small-area estimates of current and ex-
smoking behaviours. Smoking information is unavailable for 
small areas across England, so the data were generated using 
multi-level synthetic estimation techniques applied to four 
runs of the Health Survey for England (HSfE) (1998–2001). 
The report also briefl y discusses the general methodology 
and substantive results relating to the synthetic estimation of 
smoking behaviour.
A second objective was to produce an overall UK estimate 
of smoking-attributable mortality with separate fi gures for 
England, Wales, Scotland and Northern Ireland. To produce 
this estimate, the English smoking-attributable mortality 
fi gures were derived from the fi rst stage of the research 
outlined above. Figures for Scotland were available from a 
similar, parallel project undertaken by the researchers. The 
equivalent fi gures for Wales and Northern Ireland were 
derived by applying the published relative risk factors to 
national estimates of age- and sex-specifi c rates of current 
and ex-smoking. The derived attributable proportions were 
then applied to national counts of cause-, sex- and age-
specifi c mortality.
It should be emphasised that throughout this report the focus 
is on estimation. Reported fi gures are estimates, and should 
be treated as such. They refl ect expected values for the topics 
under investigation, controlling for relevant individual and 
geographical characteristics, and should not be regarded as 
absolute or exact. In the absence of direct, routine measures 
they are, however, an acceptable and available substitution.
Key fi ndings
•  Adult smoking prevalence in England (1998–2001) was 
estimated at 27%. Rates estimated for men were slightly 
higher (28%) than for women (26%).
•  Over a third of men aged under 54 and a third of women 
under 44 in England were estimated to be current 
smokers. Highest rates were found among men aged 
25–34, where prevalence was estimated to be as high as 
40%.
•  Large spatial variations were estimated across the English 
PCTs, with rates ranging from 20 to 40%.
•  Less variation was estimated at the English SHA level, 
where lowest rates are around 25% and highest rates 
were given as 30%.
•  Just over one third of adults in England were estimated 
to be ex-smokers, with higher rates estimated for men 
compared with women (35 versus 28%).
•  A strong age gradient exists in the estimated proportion of 
ex-smokers across England, with highest rates reported for 
the elderly.
•  Geographical variation in ex-smokers is estimated to range 
between 15 and 38% for English PCTs and between 24 
and 34% for English SHAs.
•  In terms of smoking-attributable mortality, it was 
estimated that between 1998 and 2002 an annual 
average of 86,500 deaths were caused by smoking in 
England.
•  Of these deaths, 62% were among men and 38% among 
women.
•  The greatest impact is on the number of lung cancer 
deaths, where just over nine in ten male lung cancer 
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deaths and eight in ten female lung cancer deaths in 
England were smoking-attributable.
•  A particularly high death toll is found for chronic 
obstructive lung disease, where it is estimated that 17,400 
deaths each year in England were caused by smoking.
•  11,500 deaths from ischaemic heart disease among 
those over 65 in England were estimated to be smoking-
attributable.
•  Across the UK it is estimated that one quarter of female 
deaths and just over one third of male deaths from 
diseases associated with smoking were attributable 
to smoking. In terms of total deaths (all causes), 
approximately 23% (men) and 12% (women) are 
attributable to smoking.
•  The number of deaths from smoking-attributable disease 
has decreased. Across the UK there were approximately 
120,000 deaths attributable to smoking in 1995, and 
just over 106,000 per annum between 1998 and 2002. 
This represents an estimated fall from just over one in fi ve 
deaths in 1995 to just under one in six deaths for the later 
period.
Looking to the future, it can be anticipated that smoking-
attributable deaths will continue to decline. The rate of this 
decline may decrease as prevalence rates level out. This 
report highlights the varying levels of estimated prevalence 
across gender and age. If sustained reductions in smoking-
attributable deaths are to be maintained, particular attention 
will need to be paid to groups where current smoking is not 
reducing – this suggests that initiatives focusing on younger 
adults will be particularly important.
3The primary aim of this project was to investigate the 
impact of smoking behaviour on mortality by providing an 
estimate of the proportion of deaths in England that are 
directly attributable to smoking. This work updates previous 
investigations (Health Education Authority, 1991; Callum, 
1998) and uses published risk factors that link smoking 
behaviour with smoking-attributable mortality.
Previous work has focused on the production of a single 
national or UK fi gure for smoking-attributable mortality, due 
to the unavailability of estimates of smoking behaviour across 
small areas. In the work presented here, synthetic estimation 
is used to derive small-area profi les of current smoking 
prevalence and the proportion who are ex-smokers. This 
allows for the description of smoking-attributable mortality 
to be undertaken across ‘bespoke’ but policy-relevant areas 
such as PCTs and SHAs.
A secondary aim was to produce an updated UK estimate of 
smoking-attributable mortality to compare with the fi gure 
provided by Callum (1998). A consequence of this objective 
was that the present study does not consider the impact of 
passive smoking on mortality. In producing an estimate of 
smoking-attributable mortality, the fi gures for England are 
derived from the fi rst stage of the project. Similar estimates 
are also available for Scotland (Moon et al., 2003). For Wales 
and Northern Ireland, direct survey estimates of national age- 
and sex-specifi c rates of smoking and ex-smoking behaviour 
are used with the published risk factors that link such 
behaviours with smoking-attributable mortality.
The specifi c objectives are to:
•  Provide profi les of smoking behaviour for the 303 PCTs 
and 28 SHAs across England
•  Estimate the smoking-attributable proportion of deaths 
occurring across SHAs and PCTs by applying a standard 
equation that links disease-specifi c risk with smoking 
behaviour
•  Provide estimates of gender-specifi c and, for certain 
diseases, age-specifi c counts of the number of smoking-
attributable deaths across disease groups for England
•  Generate estimates of the smoking-attributable proportion 
across the bespoke geographies
•  Provide a UK estimate of smoking-attributable mortality 
with summary fi gures for England, Wales, Scotland and 
Northern Ireland.
Aims and objectives
Aims and objectives
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Results from the General Household Survey indicate that 
26% of adults (aged 16 or over) smoked cigarettes in 2002 
(ONS, 2004). This percentage was made up of 27% men 
and 25% women. Although rates have fallen since the early 
1980s, the decline levelled in the mid-1990s. This trend is 
shown in Figure 1. Data for the past three years up to 2001 
are separated from the main graph, as these are based on a 
weighted sample of General Household Survey respondents 
designed to make up for under-representation of certain 
subgroups of the population. Prevalence rates varied by age. 
For both sexes, the highest rates were found among the 
20–24 year olds, with reported rates for 2001 at 39 and 35% 
for men and women, respectively.
The proportion of ex-smokers in the population remained 
relatively stable over the same period, with more men 
Background
(27%) than women (21%) stating that they were ex-regular 
smokers (Department of Health, 2003).
Smoking prevalence and mortality data for 1995 were 
used to produce the last estimate of smoking-attributable 
mortality (Callum, 1998). It was estimated that across the 
UK 120,000 deaths among people aged over 35 were due 
to smoking. This represented one in fi ve of all deaths, 84% 
of all deaths from lung cancer, and 15% of all circulatory 
diseases. In England the estimated number of deaths due 
to smoking in 1995 was 98,800, with the percentage of all 
deaths, at all ages, caused by smoking given as 26% for 
men and 12% for women. English studies since Callum’s 
report include those produced by the Royal College of 
Physicians (2000) and Peto et al. (2004). Other analyses are 
restricted to a regional (eg SWPHO, 2003) or subregional 
focus (eg Bedfordshire and Hertfordshire SHA, 2004).
Figure 1  Prevalence of smoking cigarettes among adults aged 16+ in England 1980–2002, by 
gender (Source: ONS, 2004)
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5Focusing on smoking-attributable mortality at PCT and 
SHA levels requires information on smoking and past 
smoking prevalence at these levels, as well as information 
on deaths from smoking-related disease. While relevant 
data on mortality are available, information on smoking 
prevalence has only recently become available at the 
SHA level, and is estimated by merging data from several 
runs of the HSfE. (These data became available after the 
start date of this project, and can now be downloaded in 
electronic format from the Department of Health website: 
www.dh.gov.uk/PublicationsAndStatistics/PublishedSurvey/
HealthSurveyForEngland/HealthSurveyResults/fs/en). 
National surveys such as the General Household Survey 
and the HSfE are only reliably representative at the 
regional level for any one year.
To bridge this information gap in identifying the prevalence of 
current smoking and the proportion of ex-smokers in SHAs and 
PCTs requires synthetic statistical estimation. Synthetic estimation 
allows identifi cation of the numbers of people in each SHA 
or PCT who, given certain assumptions, might be expected to 
be current or ex-smokers. Robust procedures are available to 
generate high quality synthetic estimates (Box 1). Once data on 
smoking prevalence are available, they can be used in conjunction 
with published formulae to identify smoking-attributable 
mortality. A technical account of the synthetic estimation process 
is given in Appendix 1.
Method
Box 1 Synthetic estimation: quality assurance
We use the procedure of Twigg et al. (2000). This has been:
•  Subject to peer-reviewed evaluation in a leading journal (Twigg et al., 2002)
•  Assessed and reviewed favourably by the National Centre for Social Research (NatCen) (Bajekal et al., 2004)
•  Applied and reviewed favourably in investigating the links between social capital and health (Mohan et al., 2004a,b).
The application of this procedure in the present research has been subject to extensive quality checking (Appendix 3).
Method
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Current smoking prevalence
Although this report is not concerned with ward-level 
estimates of smoking and ex-smoking prevalence, it is useful 
to look at the overall averages across the 7,932 wards of 
England, noting gender differences and the overall spread of 
the results. The estimated overall average smoking prevalence 
(for those aged 16+) is given as 27%, with a slightly higher 
average for males (28%) compared with females (26%). 
Table 1 indicates how the sex-specifi c rates vary with age. 
Highest rates are found among 25–34 year olds for men and 
16–24 year olds for women. These estimates suggest that 
over a third of men are smoking until the age of 54, and 
around a third of women do so until the age of 44. Rates 
decline to around 23 or 24% for those aged 55–64, and 
just under one fi fth smoke between the ages of 65 and 74. 
Lowest prevalences (around 10%) are reported for both men 
and women in the over-75 age group. Prevalences are lowest 
in the elder age groups partly because of quitting, but also 
partly because of the increased risk of smokers dying.
Geographical differences
The distribution of prevalences across the 303 PCTs for 
England is shown in Figure 2. The lowest prevalences are just 
under 20% and the highest is just over 40%. The average 
prevalence across PCTs is around 28%, with a standard 
deviation of 4.2%. The estimates for all PCTs are given in 
Appendix 6.
Figure 3 maps the spatial distribution of estimates of current 
smoking prevalence across the 303 PCTs for England. Highest 
rates are clustered around the urban areas of inner London, 
parts of the North East, the North West, the West Midlands 
and East Midlands. Lowest rates are found in some of the 
more rural areas such as Devon, Cornwall, East Anglia, the 
southern English Midlands, North Yorkshire, North Lancashire 
and the southern Home Counties.
In terms of SHAs, the estimated prevalences are shown in 
ascending order in Table 2 (page 9). Lowest rates (around 
25%) are estimated for Surrey, Sussex, Dorset, Somerset, 
Coventry, Warwickshire, Herefordshire, Worcestershire and 
Thames Valley. Highest prevalences are found in parts of 
London, the North East, Greater Manchester and South 
Yorkshire, where prevalence rates are predicted to be above 
30%. The prevalences are mapped in Figure 4.
Results: current and past smoking behaviour
Table 1  Estimated smoking prevalence by sex 
and age using Health Survey for England data, 
1998–2001
Age group
Estimated current smoking prevalence (%)
Males Females All Persons
16–24 36 36 36
25–34 38 35 36
35–44 34 30 32
45–54 30 28 29
55–64 24 23 23
65–74 18 18 18
75+ 10 10 10
Figure 2  Estimated smoking prevalence across PCTs
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Figure 3  Estimated current smoking: PCTs
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Figure 4  Estimated current smoking: SHAs
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9Ex-smoking behaviour
The overall average percentage of ex-smokers across the 
7,932 wards of England is estimated at 31%. There are 
slightly higher rates for males (35%) compared with females 
(28%). The age- and sex-specifi c estimated percentages are 
shown in Table 3.
There is a strong age gradient in the estimated proportion 
of ex-smokers across both sexes, with higher proportions 
reported in the higher age groups. Gender differences are 
negligible below age 44; above this age higher proportions 
are estimated for males compared with females. For those 
aged over 75, over two thirds of men are estimated to be 
ex-smokers compared with just over 40% of women. These 
age and gender differences refl ect historical age–sex variation 
in smoking prevalence.
The overall distribution of estimated ex-smoking across the 
303 PCTs is shown in Figure 5. The lowest estimated rate is 
just under 15% and the highest is around 38%. The average 
percentage is around 30%, with a standard deviation of 
3.4%. Again the full data set is given in Appendix 6.
Figure 6 maps the spatial distribution of estimates of ex-
smoking percentages across the 303 PCTs for England. High 
Table 2  Estimates of current smoking prevalence: SHAs
SHA code SHA
Current 
smoking 
prevalence 
(%)
Q19 Surrey and Sussex 25
Q22 Dorset and Somerset 25
Q28 Coventry, Warwickshire, Herefordshire and Worcestershire 26
Q16 Thames Valley 26
Q02 Bedfordshire and Hertfordshire 26
Q20 Avon, Gloucestershire and Wiltshire 27
Q08 South West London 27
Q25 Leicestershire, Northamptonshire and Rutland 27
Q01 Norfolk, Suffolk and Cambridgeshire 27
Q03 Essex 27
Q26 Shropshire and Staffordshire 27
Q21 South West Peninsula 27
Q17 Hampshire and Isle of Wight 27
Q13 Cumbria and Lancashire 28
Q11 North and East Yorkshire and Northern Lincolnshire 28
Q18 Kent and Medway 28
Q04 North West London 28
Q24 Trent 28
Q27 Birmingham and the Black Country 29
Q15 Cheshire and Merseyside 29
Q12 West Yorkshire 30
Q05 North Central London 31
Q10 County Durham and Tees Valley 31
Q14 Greater Manchester 31
Q06 North East London 31
Q23 South Yorkshire 32
Q07 South East London 32
Q09 Northumberland, Tyne & Wear 33
Results: current and past smoking behaviour
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rates are found along the coastal areas of England and in the 
southern Home Counties, refl ecting the concentrations of 
elderly people. Lowest rates are found in the urban areas in 
and around London, the North West, North East and West 
Midlands. When the estimated proportion of ex-smokers is 
correlated with current smoking prevalence, a coeffi cient 
of r = –0.650 is derived (P < 0.00), suggesting that higher 
proportions of ex-smokers are found in areas where current 
smoking prevalence is low. The pattern is also consistent with 
the suggestion that higher rates of smoking cessation are 
found in more affl uent areas.
The estimated proportions of ex-smoking across the SHAs 
are shown in ascending order in Table 4. It is notable that 
some of the SHAs with the highest ex-smoking rates 
are also estimated to have the lowest current smoking 
prevalence (eg Surrey and Sussex; Dorset and Somerset), 
again refl ecting population age structure. The ex-smoking 
percentages for SHAs are also mapped in Figure 7.
Table 3  Estimated proportions of ex-smokers by 
age group and sex
Age group
Estimated proportion of ex-smokers (%)
Males Females All Persons
16–24 11 12 12
25–34 19 20 20
35–44 23 23 23
45–54 36 28 32
55–64 49 33 41
65–74 59 38 48
75+ 68 42 52
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Figure 5  Estimated ex-smoking across PCTs, England
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Figure 6  Ex-smoking estimates: PCTs
Results: current and past smoking behaviour
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Table 4  Estimated proportion of ex-smokers: SHAs
SHA code SHA
Ex-smoking 
prevalence 
(%)
Q06 North East London 24
Q27 Birmingham and the Black Country 26
Q04 North West London 26
Q07 South East London 27
Q05 North Central London 27
Q14 Greater Manchester 28
Q10 County Durham and Tees Valley 28
Q08 South West London 29
Q09 Northumberland, Tyne & Wear 29
Q12 West Yorkshire 29
Q15 Cheshire and Merseyside 29
Q25 Leicestershire, Northamptonshire and Rutland 30
Q23 South Yorkshire 30
Q26 Shropshire and Staffordshire 30
Q13 Cumbria and Lancashire 30
Q28 Coventry, Warwickshire, Herefordshire and Worcestershire 30
Q02 Bedfordshire and Hertfordshire 31
Q24 Trent 31
Q16 Thames Valley 31
Q20 Avon, Gloucestershire and Wiltshire 31
Q11 North and East Yorkshire and Northern Lincolnshire 32
Q18 Kent and Medway 32
Q03 Essex 32
Q01 Norfolk, Suffolk and Cambridgeshire 32
Q17 Hampshire and Isle of Wight 32
Q21 South West Peninsula 33
Q22 Dorset and Somerset 34
Q19 Surrey and Sussex 34
13Results: current and past smoking behaviour
Figure 7  Ex-smoking estimates: SHAs
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Using the methodology outlined in Appendix 1, smoking-
attributable mortality was calculated for each PCT. The PCT 
data were then aggregated to provide disease- and sex-
specifi c counts and proportions for England. Table 5 shows, 
for England, the observed number of deaths by cause; the 
number estimated to be smoking-attributable (negative in 
the case of Parkinson’s disease and endometrial cancer); and 
the percentage of those deaths attributable to smoking. In 
the case of Parkinson’s disease and endometrial cancer, this 
percentage represents the proportion inhibited by smoking. 
The percentages are rounded to the nearest whole number, 
and the number of smoking-attributable deaths are rounded 
to the nearest 100.
For England as a whole it is estimated that, on average, 
each year 86,500 deaths were caused by smoking over 
the period 1998–2002. This represents an average of over 
1,663 deaths per week, 237 deaths every day, and nearly 10 
deaths an hour. Of the total number of smoking-attributable 
deaths, just over 62% (53,800) are among males and 38% 
are among women (32,700). In contrast, 900 male deaths 
and 500 female deaths caused by Parkinson’s disease 
are estimated to have been prevented through smoking. 
Furthermore, 200 deaths from endometrial cancer are 
estimated to have been prevented among women. The net 
overall fi gure for smoking-attributable mortality is therefore 
given as 84,900.
In terms of cause of death, the greatest attributable 
proportion is given for lung cancer. Just over nine in ten male 
lung cancer deaths, and eight in ten female lung cancer 
deaths, are estimated to be smoking-attributable. Over 70% 
of mortality due to cancer of the oesophagus is estimated 
to be smoking-attributable, and over three quarters of 
male upper respiratory cancer deaths are due to smoking. 
High attributable proportions are also present in the case 
of chronic obstructive lung disease, where more than eight 
in ten deaths are smoking-attributable. In terms of the 
circulatory diseases, the majority of deaths due to ischaemic 
heart disease between ages 35 and 54 are smoking-
attributable, with the proportion slightly higher for women 
(63%) than men (57%). Similarly over half the deaths from 
cerebrovascular disease in the 35–54 age groups are also 
smoking-attributable, and over 60% of all deaths from aortic 
aneurysm are estimated to be smoking-attributable. While 
relative proportions may be lower for some disease and age 
categories, the absolute number affected is much larger. For 
example, just over a quarter of male deaths and over one 
fi fth of female deaths from ischaemic heart disease in the 
65–74 group are smoking-attributable – this is estimated at 
4,100 male deaths and 7,400 female deaths.
The geography of female and male smoking-attributable 
mortality across the PCTs is shown in Figures 8–10, 
respectively. In these maps the causes are grouped together; 
disaggregating the causes across the 303 PCTs would 
lead to relatively small numbers and unreliable results. The 
percentages are based on the net fi gure (subtracting the 
‘prevented’ Parkinson’s disease and endometrial cancer 
deaths from the total number of attributable deaths). The 
percentages are based on the fi ve years of available mortality 
data, and represent the attributable proportion among those 
over 35 years using a base derived from the total number of 
deaths for the diseases listed in Table 5. The geographical 
pattern for males, females and all persons is fairly similar. 
Higher proportions of smoking-attributable mortality are 
found in the North East, North West, parts of the Midlands, 
East Midlands, parts of London and northern Kent. The 
geographical pattern in both maps picks up the underlying 
pattern of smoking prevalence shown in Figure 3.
Results: smoking-attributable mortality
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Table 5  Deaths attributable to smoking as percentage of all deaths from that disease: England
(1998–2002)
Disease
Men Women
Observed
Attributable 
number
Attributable 
percentage Observed
Attributable
number
Attributable 
percentage
Cancer
 Lung  16,957  15,400 91  10,466  8,300 80
 Upper respiratory  653  500 77  188  100 58
 Oesophagus  3,575  2,500 70  2,110  1,500 72
 Bladder  2,755  1,300 49  1,404  300 23
 Kidney  1,509  600 42  942  100 7
 Stomach  3,387  1,200 35  2,066  300 12
 Pancreas  2,710  700 26  2,904  900 31
 Unspecifi ed site  4,536  1,500 33  4,738  300 7
 Myeloid leukaemia  1,034  200 19  927  100 12
Respiratory 
 Chronic obstructive lung disease  11,219  9,700 87  9,036  7,600 84
 Pneumonia 35–64  542  200 34  324  200 51
 Pneumonia 65+  6,377  1,600 24  9,752  1,500 15
Circulatory 
 Ischaemic heart disease 35–54  3,676  2,100 57  767  500 63
 Ischaemic heart disease 55–64  7,084  2,900 41  2,084  700 34
 Ischaemic heart disease 65–74  15,337  4,100 27  7,454  1,600 22
 Ischaemic heart disease 75+  30,470  2,900 10  35,977  2,700 8
 Cerebrovascular disease 35–54  773  400 58  680  400 52
 Cerebrovascular disease 55–64  1,298  400 33  967  300 35
 Cerebrovascular disease 65–74  3,896  700 17  3,380  1,300 38
 Cerebrovascular disease 75+  13,841  500 4  28,025  500 2
 Aortic aneurysm  5,311  3,400 64  3,354  2,200 65
 Myocardial degeneration  278  100 26  960  200 18
 Atherosclerosis  416  100 22  754  100 17
Digestive
 Stomach/duodenal ulcer  1,482  800 54  1,649  1,000 58
Diseases prevented by smoking 
 Parkinson’s disease  1,677  –900 –51  1,345  –500 –38
 Endometrial cancer na na na  810  –200 –20
Results: smoking-attributable mortality
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Table 5  Deaths attributable to smoking as percentage of all 
deaths from that disease: England
(1998–2001)
Disease
All Persons
Observed
Attributable 
number
Attributable 
percentage
Cancer
 Lung 27423 23700 87
 Upper respiratory 841 600 73
 Oesophagus 5685 4000 71
 Bladder 4159 1700 40
 Kidney 2451 700 28
 Stomach 5453 1400 27
 Pancreas 5614 1600 29
 Unspecifi ed site 9274 1800 20
 Myeloid leukaemia 1961 300 16
Respiratory 
 Chronic obstructive lung disease 20255 17400 86
 Pneumonia 35–64 866 300 40
 Pneumonia 65+ 16129 3000 19
Circulatory 
 Ischaemic heart disease 35–54 4443 2600 58
 Ischaemic heart disease 55–64 9168 3600 39
 Ischaemic heart disease 65–74 22791 5800 25
 Ischaemic heart disease 75+ 66447 5700 9
 Cerebrovascular disease 35–54 1453 800 55
 Cerebrovascular disease 55–64 2265 800 34
 Cerebrovascular disease 65–74 7276 1900 27
 Cerebrovascular disease 75+ 41866 1000 2
 Aortic aneurysm 8665 5600 64
 Myocardial degeneration 1238 200 20
 Atherosclerosis 1170 200 19
Digestive
 Stomach/duodenal ulcer 3131 1800 56
Diseases prevented by smoking 
 Parkinson’s disease 3022 -1400 -45
 Endometrial cancer na
Note: the 'All person attributable number’ may not equate with the men and women total due to rounding and percentages 
have been calculated before rounding of the attributable number.
Continued from page 15
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Figure 8  Female smoking-attributable mortality: PCTs (percentage represents percentage of all deaths of those 
aged 35+ from causes associated with smoking; average fi gure for 1998–2002)
Greater London
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Figure 9  Male smoking-attributable mortality: PCTs (percentage represents percentage of all deaths of those aged 
35+ from causes associated with smoking; average fi gure for 1998–2002))
Greater London
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Percentage
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Figure 10  Smoking-attributable mortality (persons): PCTs (percentage represents percentage of all deaths of those 
aged 35+ from causes associated with smoking; average fi gure for 1998–2002)
Greater London
37-43
34-36
31-33
28-30
23-27
Percentage
see
inset
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Table 6 provides the net proportion of deaths attributable 
to smoking for the SHAs. The protective effect of smoking 
in terms of preventing endometrial cancer and Parkinson’s 
disease deaths is not discernible after rounding. Again, the 
base used to calculate these percentages is the total number 
of deaths from the causes listed in Table 5, and they have 
been calculated using fi ve years of mortality information. The 
average annual count across these fi ve years is also provided 
as an insight into the annual deaths attributable to smoking 
across the SHAs.
Table 6  Smoking-attributable mortality – percentages and counts across SHAs
SHA 
code Name
Smoking-attributable 
mortality (%)
Average annual smoking-
attributable mortality 
counts 1998–2002
Males Females
All 
Persons Males Females
All 
Persons
Q01 Norfolk, Suffolk and Cambridgeshire 35 21 28 2,200 1,200 3400
Q02 Bedfordshire and Hertfordshire 38 23 31 1,500 800 2300
Q03 Essex 36 23 30 1,600 1,000 2600
Q04 North West London 39 25 32 1,400 800 2200
Q05 North Central London 39 24 32 1,000 600 1600
Q06 North East London 42 25 36 1,500 800 2300
Q07 South East London 39 24 35 1,500 900 2400
Q08 South West London 38 24 31 1,100 700 1700
Q09 Northumberland, Tyne & Wear 42 30 36 2,000 1,300 3300
Q10 County Durham and Tees Valley 40 29 34 1,500 1,000 2500
Q11 North and East Yorkshire and Northern Lincolnshire 37 24 31 1,900 1,200 3100
Q12 West Yorkshire 40 27 33 2,400 1,600 3900
Q13 Cumbria and Lancashire 38 25 31 2,400 1,500 3900
Q14 Greater Manchester 41 27 34 3,300 2,100 5400
Q15 Cheshire and Merseyside 41 28 34 3,000 2,000 5000
Q16 Thames Valley 36 22 29 1,700 1,000 2700
Q17 Hampshire and Isle of Wight 36 22 29 1,700 1,000 2800
Q18 Kent and Medway 38 24 31 1,700 1,000 2800
Q19 Surrey and Sussex 34 21 27 2,600 1,600 4200
Q20 Avon, Gloucestershire and Wiltshire 35 21 28 2,100 1,200 3300
Q21 South West Peninsula 35 21 28 1,800 1,000 2900
Q22 Dorset and Somerset 33 20 27 1,300 800 2100
Q23 South Yorkshire 39 27 33 1,600 1,000 2700
Q24 Trent 38 24 31 3,000 1,800 4800
Q25 Leicestershire, Northamptonshire and Rutland 36 23 30 1,500 800 2300
Q26 Shropshire and Staffordshire 37 23 30 1,600 900 2600
Q27 Birmingham and the Black Country 39 25 32 2,700 1,500 4200
Q28 Coventry, Warwickshire, Herefordshire and Worcestershire 35 22 29 1,500 900 2400
Note that the overall England total may not be the same as that in Tables 7 and A1 due to rounding to the nearest 100. The ‘All person attributable 
number’ may not equate with the men and women total due to rounding and percentages have been calculated before rounding of the 
attributable number.
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In compiling a UK estimate of smoking-attributable 
mortality, the England component was derived from the 
work summarised previously. The Scottish fi gure was derived 
from similar work undertaken by Moon et al. (2003). The 
equivalent fi gures for Wales and Northern Ireland were 
derived by applying the attributable risk formula used in 
the above reports to national estimates of age- and sex-
specifi c rates of current and ex-smoking. These were derived 
from the 1998 Welsh Health Survey (National Assembly 
for Wales, 2000) and the 2000–01 Continuous Household 
Survey (NISRA, 2002), respectively. The derived attributable 
proportions were then applied to national counts of 
cause-, sex- and age-specifi c mortality for Wales (supplied 
by National Statistics) and Northern Ireland (supplied by 
the Northern Ireland Statistics and Research Agency). All 
mortality sources used fi ve years of data (1998–2002), and 
the results shown in Table 7 represent the annual average 
smoking-attributable mortality across these years. Again, 
estimates have been rounded to the nearest 100.
It is estimated that, in total, 106,100 persons die each 
year from smoking-attributable causes across the UK. It 
is estimated that 23% of male deaths from all causes are 
attributable to smoking. For women the equivalent fi gure is 
lower, at 12%. In terms of constituent countries, the highest 
proportion is given for Scotland, where almost one in fi ve 
deaths are smoking-attributable (19%). For males in Scotland 
over a quarter of deaths are smoking-attributable, and for 
women the estimated percentage is 14%. Northern Ireland 
is estimated to have the lowest attributable proportions, 
with 21% of male deaths and 10% of female deaths being 
attributable to smoking.
The equivalent total for 1995 was 120,000 (Callum, 1998). 
Although we cannot be certain there has been a real reduction 
in the number of deaths due to smoking, the reduced fi gure 
presented here is in line with trends. An update produced by 
the Royal College of Physicians (2000), using 1997 mortality 
data, 1996 smoking information and the Callum methodology, 
resulted in an estimate of 117,400 attributable deaths. A 
further reduction was evident in the work of Peto et al. (2004). 
Using a different methodology, they suggested that 114,000 
deaths were due to smoking in 2000. The results in the 
present report appear to be in line with this reducing trend in 
smoking-attributable mortality. They are the fi rst estimates to 
take account of subnational variations in smoking behaviour 
and geographical differences in mortality. This, together with 
other methodological differences and the reducing trend, 
accounts for the difference between the estimate in the 
present report and those produced previously.
Producing a UK estimate of smoking-attributable 
mortality
Table 7  Smoking-attributable mortality across the UK, annual averages 1998–2002
Nation
Total number of deaths1 Smoking-attributable 
mortality2
Smoking-attributable proportion
Males Females Persons Males Females Persons Males Females Persons
England  241,222  265,847  507,069  53,800  32,700  86,500 0.22 0.12 0.17
Scotland  27,463  30,683  58,146  7,100  4,200  11,300 0.26 0.14 0.19
Wales  15,962  17,738  33,700  3,800  2,200  6,000 0.24 0.12 0.18
Northern Ireland  7,174  7,758  14,932  1,500  800  2,300 0.21 0.10 0.15
Total UK  293,061  322,556  615,617  66,200  39,900  106,100 0.23 0.12 0.17
1From all causes of death. 
2These fi gures do not include an adjustment for deaths that may have been prevented by smoking (ie endometrial cancer and Parkinson’s disease).
Producing a UK estimate of smoking-attributable mortality
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A single important summary point needs to be made about 
the data presented in this report. These data represent a 
reasoned, robust ‘best guess’ as to smoking prevalence and 
smoking-attributable mortality. The estimates of smoking 
prevalence at local level almost certainly will not mirror 
precisely any available measures from local studies or surveys, 
but past work and current investigation have shown that 
they are likely to be similar. The estimates of smoking-
attributable mortality are, nonetheless, in line with those 
produced for 1995 (Callum, 1998). Some underestimation 
of mortality has undoubtedly occurred, both in the work 
reported here and in that reported by Callum, because 
passive smoking has not been taken into account. With this 
in mind, however, the estimated reduction in the overall 
fi gure for smoking-attributable deaths in England and the UK 
is an expected consequence of the overall reduction in deaths 
from diseases such as lung cancer, ischaemic heart disease 
and cerebrovascular disease.
It follows from these limitations that the results from this 
research (presented in the accompanying electronic fi les on 
the HDA website (www.hda.nhs.uk)) must be used with 
caution. The data indicate expected levels of smoking, ex-
smoking and smoking-attributable mortality, given the local 
expression of national associations between key indicators 
and these target variables. Point prevalences should always 
be clearly presented as estimates, and direct comparisons 
between PCTs or SHAs should be avoided. For preference, it 
is recommended that users adopt statements such as those 
listed in Box 2. Users should also round raw fi gures to the 
nearest 100 for smoking-attributable mortality and focus only 
on all-cause mortality across both genders when considering 
PCT data. Similarly, percentages should be rounded to 
the nearest whole number when discussing prevalence 
percentages.
It is anticipated that, using this approach, SHAs and PCTs 
will wish to use the information as a basis for assessing 
Conclusion: limitations and implementation
Box 2 Reporting the fi ndings
Smoking and ex-smoking prevalence
•  Given the characteristics of the local population and the regional setting, we would expect a smoking (or ex-smoking) 
prevalence of approximately x% within X SHA (or PCT).
•  Given the characteristics of the local population and regional setting, X SHA (or PCT) is estimated to be within the 
highest (or lowest) 10% (or 5%, 15%, 20% etc) of PCTs/SHAs in terms of smoking prevalence (or ex-smoking 
prevalence).
Smoking-attributable mortality
•  Given the characteristics of the local population and the regional setting, we would expect around x deaths per year to 
be caused by smoking.
•  Given the characteristics of the local population, the regional setting and local information on cause of death, X SHA (or 
PCT) is estimated to be within the highest (or lowest) 10% (or 5%, 15%, 20% etc) of PCTs/SHAs in terms of smoking-
attributable mortality.
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the need for health promotion initiatives and public health 
campaigns.
Looking to the future, it can be anticipated that smoking-
attributable deaths will continue to decline. The rate of this 
decline may decrease as prevalence rates level out. This 
report highlights the varying levels of estimated prevalence 
across gender and age. If sustained reductions in smoking-
attributable deaths are to be maintained, particular 
attention will need to be paid to groups where current 
smoking is not reducing – this suggests that initiatives 
focusing on younger adults will be particularly important.
Conclusion: limitations and implementation
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Synthetic estimation has to work with the sampling structure 
of data sets containing information on current and ex-
smoking. Typically this design samples individuals in postcode 
sectors in regions. It does not involve SHAs or PCTs; regions 
are larger than either. Hence it is necessary to build estimates 
of PCT and SHA smoking behaviour from a lower level. 
Following Twigg et al. (2000) and Heady et al. (2003), electoral 
wards were used as the building blocks in this research; wards 
are generally similar in size to postcode sectors.
Estimating smoking behaviour for wards
Estimation used the technically robust and innovative 
framework for generating small-area data on smoking 
behaviour documented by Twigg et al. (2000). This approach 
has recently been used in a similar, parallel exercise for 
Scotland (Moon et al., 2003). The approach employs multi-
level modelling, an extension of the more familiar generalised 
linear regression model. Regression builds an equation that 
estimates a target response variable in terms of a number 
of candidate predictor variables. In this case the response 
might be whether or not a person smokes, and the predictors 
would be variables that are thought to relate closely to 
smoking, eg age, sex or social status. Multi-level modelling 
takes this a stage further, recognising that the chance of 
an individual smoking refl ects not only that individual’s 
personal characteristics, but also the characteristics of the 
environment in which the person lives. In short, the approach 
acknowledges that people’s behaviour may be infl uenced by 
their environment. The characteristics of multi-level analysis 
and the associated statistical theory are well documented 
(Goldstein, 1995; Kreft and de Leeuw, 1998; Snijders and 
Bosker, 1999). Health applications are discussed by Leyland 
and Goldstein (2001).
Data sources
Multi-level models of past and current smoking behaviour 
were developed using individual data from the Health Survey 
for England (HSfE). This is an annual survey commissioned 
by the Department of Health to provide regular information 
on various aspects of the nation’s health that cannot be 
obtained from other sources. It is designed to monitor 
certain health conditions and also to investigate risk factors 
associated with certain diseases. A full description of the 
survey content and sampling framework is provided by the 
National Centre for Social Research and University College 
London, Department of Epidemiology and Public Health 
(NCRS/UCL, 2004).
To improve the reliability of results, information from 
four runs of HSfE data was merged. These related to the 
individual responses provided for 1998–2001. The multi-
stage, clustered design of this survey results in a sample 
of individuals being selected from a sample of postcode 
sectors. Normally the public data set provides information 
on the clustering of individuals within postcode sectors 
without disclosing the identifi cation (and hence location) of 
the sectors. For this study the research team were allowed 
access to the identifi cation details of these sectors so that 
additional data from the 2001 Census could be merged with 
HSfE information. A working contract was agreed with the 
National Centre for Social Research that did not threaten the 
anonymity of any HSfE survey respondents. The required runs 
of the HSfE were sourced from the UK Data Archive.
The multi-level structure of the working data set comprised 
individuals (level 1) nested within postcode sectors (level 
2). In turn, these level 2 units nested within standard 
government offi ce regions. The multi-level structure is 
defi ned in Table A1.
Appendix 1 Technical background
Table A1  The multi-level structure
Level Unit N
1 Individuals  47,341
2 Postcode sectors units  2,053
3 Government offi ce regions  9
Appendix 1 Technical background
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Response variables
Estimates of two aspects of smoking behaviour were needed 
to calculate smoking-attributable mortality: current and past 
smoking prevalence. Respondents in the HSfE are asked 
about their current and past cigarette-smoking behaviour, 
and two binary outcome variables can be derived from 
the survey responses. One variable indicates whether or 
not an individual is a current smoker (Y1) and the other 
indicates whether or not the individual used to smoke 
cigarettes (Y2). Across the four years (1998–2001) of HSfE 
survey information, the percentage of adult respondents 
who are current smokers is given as 26.5%, and 31.5% of 
respondents report that they have given up.
Predictor or explanatory variables
Within a multi-level modelling framework it is permissible to 
have predictor variables that relate either to individual-level 
infl uences on the response, or to higher-level (ecological or 
area) infl uences.
Individual level
While there are numerous individual level predictors that 
might be identifi ed from the HSfE, the actual selection is 
crucially constrained by the subsequent use of the models 
within a predictive framework. Individual level predictor 
variables must therefore be present in both the HSfE and 
the 2001 Census, and must be defi ned in similar ways. It is 
possible to use complex cross-tabulations of routine local 
base statistics from the UK Census to provide counts of the 
numbers of individuals in each ward who fall into particular 
sociodemographic categories. The most detailed cross-
tabulation available at census ward level and relevant to 
health-related behaviour is age (grouped into bands), marital 
status and gender. The individual-level explanatory variables 
used in the models are therefore age, gender and marital 
status. Ideally it would be useful to include other individual-
level variables, such as social class and/or ethnicity. Due to 
the constraints listed above concerning availability of small-
area cross-tabulation, count data from the 2001 Census 
and defi nitional consistency across the data sources, these 
variables could not be included.
Marital status is defi ned as a dichotomous variable, those 
stating they are single, divorced, widowed or a cohabitee 
being contrasted with those who are married, married 
and now separated, or who have remarried. Different 
arrangements of this classifi cation were tested, and this 
dichotomy was chosen on the grounds of model parsimony 
and the need to work with an identical classifi cation from the 
population census. Age is split into the following age bands: 
16–24, 25–34, 35–44, 45–54, 55–64, 65–74, 75+.
Ecological or area data
Access to the postcode sector identifi cation details of the 
HSfE survey respondents allowed linkage of the postcode 
sector to 2001 Census output area. Postcode sector 
characteristics were aggregated from constituent Census 
output areas. A range of such ecological variables were 
attached to the respondents in the HSfE and tested for 
signifi cance in both the current and past smoking models.
Models of smoking behaviour
Each model of smoking behaviour included the individual 
age, gender and marital status terms, and interactions 
between any combinations of these (where they were found 
to be statistically signifi cant). Similarly, a slightly different 
array of ecological variables and cross-level interactions 
(between individual and area characteristics) was generated 
for each model.
The resulting models and their parameter estimates are 
provided in Appendix 2. In summary, the results indicate that 
the chance of being a current smoker is approximately 23% 
if you are categorised as the stereotypical individual (female, 
in the ‘married’ group, aged 35–44, living in a typical or 
average area in terms of social grade make-up, ethnicity, 
large housing, rented tenure, level of dependent children 
and economically inactive males – and equate to all of the 
listed interactions). This percentage is obtained by taking 
the antilogit of –1.186 (the intercept term). If, however, 
you happen to be single, but otherwise the stereotypical 
individual, this percentage increases to around 39%. An 
increase is also reported for being male (28%), and also 
for those in the youngest age group (33%), but otherwise 
stereotypical individuals. Smoking prevalence decreases for 
those aged 55 and above, with the lowest rates reported for 
those aged 75 and over (7%). Interestingly, while the main 
effects of being single or being male increase the chance of 
smoking, the interaction of these (being single and male) 
slightly reduces the impact of these individual terms. A similar 
effect is seen for the interaction of marital status and age 
as well as gender and those aged over 45. As expected, the 
chances are reduced for individuals living in areas where 
there is a high percentage of social grade A and B, and also 
where there is a high percentage of households with more 
than six rooms. The effect of living in a community that has a 
high percentage of non-whites also reduces the likelihood of 
being a current smoker, whereas high percentages of rented 
tenure increase the likelihood.
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The results of the ex-smoking model indicate that the 
chances of being an ex-smoker are approximately 24% 
(for the stereotypical individual, who has a slightly different 
defi nition in terms of area characteristics and interactions for 
this model; see Appendix 1 for details). Being ‘single’ reduces 
the chance of being an ex-smoker slightly to around 22%, 
whereas being male increases the chance slightly, to 26%. 
The logit values illustrate the strong age gradient and show 
that the chance of being an ex-smoker is approximately 42% 
if aged over 75 (and otherwise the stereotypical individual). 
Signifi cant positive interactions are given for the gender 
and age interaction (for those over 45) and also for marital 
status and those over 65. In contrast, the chance of being 
an ex-smoker is reduced for the interaction of marital status 
and gender, and marital status and the youngest age group. 
In terms of area effects, the chance of being an ex-smoker is 
reduced with an increase in the percentage of people in low 
social grade; the percentage of households with dependent 
children; the percentage of female unemployment; and 
the percentage of non-whites. In contrast, the chances are 
increased with an increase in the percentage of households 
with more than one car; and in levels of overcrowding.
Generating predictions of current and past 
smoking behaviour
Multi-level models take into account individual and local 
infl uences on the likelihood that an individual will be a 
current smoker, or the likelihood that someone has given 
up. Predictions were generated forwards using the model 
equations, then aggregated to the larger geographies of PCTs 
and SHAs. Lookup tables exist that link this ward geography 
with other higher-level administrative geographies such as 
PCTs and SHAs, ensuring that such procedures can be largely 
automated. Appendix 3 provides a discussion of the quality 
of the estimates.
There are a total of 7,987 census wards across England. 
Due to confi dentiality restrictions regarding small 
populations, demographic and/or other area characteristics 
were unavailable for a total of 55 wards (16 of these 
were in London). The Offi ce for National Statistics (ONS) 
amalgamates the data for these wards within a neighbouring 
ward to form a ‘standard table ward’ for census reporting 
purposes. The details of the wards involved in this latter 
amalgamation are given in Appendix 4. Predictions of 
smoking behaviour were therefore calculated for 7,932 
wards in England.
The ward-level predictions were aggregated to form 
estimates of smoking prevalence and past smoking behaviour 
for the 303 PCTs and 28 SHAs across England. ONS provided 
details on defi nitions of PCTs based on census wards as 
of November 2003. Details were also provided on the link 
between PCTs and SHAs as of 1 April 2003. Unfortunately 
wards do not always nest within PCTs, and there are 110 
wards whose area straddles two PCTs. ONS provided details 
of these split wards and, based on the nature of the split, the 
ward was allocated to the PCT in which the largest part of 
the ward was found.
Estimating smoking-attributable 
mortality
Estimates of smoking-attributable deaths are based on 
data from three sources: published factors for mortality of 
current and ex-smokers from various diseases known to 
be associated with smoking; estimates of age- and sex-
specifi c current and ex-smoking behaviour for the target 
geographies; and counts of death by cause for those 
geographies disaggregated by age and sex.
Risk of death from smoking
Callum (1998) investigated smoking-attributable mortality 
within England for smoking and mortality data collected in 
1995. In essence, the Callum methodology followed that 
used to estimate deaths in the USA caused by smoking 
(US DHHS, 1989). The excess risk of death for current and 
ex-smokers compared with those who have never smoked 
was derived from a prospective study of 1 million adults 
in the USA undertaken by the American Cancer Society in 
the 1980s (see Callum, 1998). The published relative risks 
are considered to be transferable to the UK situation. Table 
A2 lists the causes of death known to be associated with 
smoking and the sex-specifi c relative risks for current and ex-
smokers. These published relative risks continue to be used 
by other investigators (eg Royal College of Physicians, 2000) 
and, while there have been suggestions that other diseases 
should be added, there is as yet no information available 
on the relative risks involved. The International Agency for 
Research on Cancer, for example, suggests that cancer of the 
nasal cavities, nasal sinuses and liver are smoking-attributable 
(IARC, 2002). After due consideration of the absence of 
alternative data and the relatively stable differential risk of 
mortality accruing to smokers, it was decided to use again 
the relative risks employed in the Callum (1998) study. This 
had the additional analytical gain of enabling comparability 
with Callum’s study. Using the same relative risks as previous 
studies allows for a more robust comparison of research 
results.
Appendix 1 Technical background
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Each value represents the risk of a person in the relevant 
smoking and gender category dying of that disease, 
compared with the risk for someone who has never smoked. 
Factors greater than unity represent an increased risk of 
death. For the majority of diseases the factors, as published, 
apply to persons aged over 35. Age-specifi c risks are given 
for pneumonia, ischaemic heart disease and cerebrovascular 
disease, and differences in relative risks exist between men 
and women. There are many reasons for this, linked to 
current and historical smoking prevalences as well as to 
differential environmental exposures.
Relative risk factors less than unity are also published for 
two diseases that may be inhibited by smoking: Parkinson’s 
disease and endometrial cancer. These estimates are subject 
to a rather higher level of uncertainty than those published in 
Table A2. The relative risks for these two diseases are given in 
Table A3.
Table A2  Relative mortality risks by disease for current and 
ex-smokers, male and female
Disease
Male smokers Female smokers
Current
(rc)
Ex
(rf)
Current
(rc)
Ex
(rf)
Cancer
 Lung  26.6 8.2  13.6 4.1
 Upper respiratory sites  10.6 3.0  6.1 1.5
 Oesophagus  5.3 4.0  9.3 3.1
 Bladder  2.9 2.1  1.6 1.5
 Kidney  2.8 1.6  1.3 1.0
 Stomach  2.1 1.6  1.2 1.3
 Pancreas  2.2 1.1  2.3 1.5
 Unspecifi ed site  4.4 2.3  2.1 1.2
 Myeloid leukaemia  1.4 1.3  1.2 1.3
Respiratory
 Chronic obstructive lung disease  14.1 8.4  14.0 8.6
 Pneumonia 35–64  2.3 1.3  4.6 1.1
 Pneumonia 65+  1.9 1.3  2.0 1.1
Circulatory
 Ischaemic heart disease 35–54  4.2 1.9  5.2 2.9
 Ischaemic heart disease 55–64  2.6 1.6  3.0 1.1
 Ischaemic heart disease 65–74  1.7 1.4  2.1 1.2
 Ischaemic heart disease 75+  1.4 1.1  1.4 1.1
 Cerebrovascular disease 35–54  5.1 1.1  4.5 1.1
 Cerebrovascular disease 55–64  2.8 1.1  3.2 1.1
 Cerebrovascular disease 65–74  2.1 1.0  3.0 1.6
 Cerebrovascular disease 75+  1.4 1.0  1.2 1.0
 Aortic aneurysm  5.3 2.6  8.2 1.6
 Myocardial degeneration  2.1 1.2  1.7 1.2
 Atherosclerosis  1.9 1.1  2.2 0.8
Digestive
 Stomach/duodenal ulcer  4.5 1.6  6.4 1.4
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Calculating the smoking-attributable 
proportion
For each disease, each gender and, where applicable, each 
age band, an expression was evaluated that linked estimates 
of PCT-based smoking behaviour with the published relative 
risks. The formula is given as:
AP = {[Pc(Rc – 1) + Pf(Rf – 1)]}/{[1 + Pc(Rc – 1) + Pf(Rf – 1)]}
where
AP is the attributable proportion for each disease
Pc is the proportion of the population who are current 
smokers
Pf is the proportion of the population who are ex-smokers
Rc is the relative risk factor for current smokers
Rf is the relative risk factor for ex-smokers.
Calculation of gender- and (where applicable) age-specifi c 
attributable proportions for each of the diseases listed in 
Tables A2 and A3 required the substitution of the appropriate 
relative risk factors into the expression and its application 
to the relevant estimated proportions of smokers and ex-
smokers. This generated an attributable proportion for each 
disease, each gender and, where applicable, for each age 
group in each ward. Although the relative risk values do not 
vary with geography, the prevalence estimates of smoking 
behaviour do, and the attributable proportions are location-
specifi c.
Death information
To estimate the number of deaths that occur due to smoking, 
the two dimensions of smoking behaviour (current and ex-
smoking) and the estimates of attributable risk have to be 
combined with observed counts of mortality to derive the 
smoking-attributable proportion. Counts of death in England, 
covering fi ve years from 1998 to 2002 inclusive, were made 
Table A3  Relative mortality risks for diseases 
inhibited by smoking
Male smokers Female smokers
Disease
Current
(rc)
Ex
(rf)
Current
(rc)
Ex
(rf)
Parkinson’s disease 0.5 0.5 0.5 0.5
Endometrial cancer na na 0.7 0.7
available at ward level. The data covered all deaths from the 
diseases listed in Tables A2 and A3. Each death was recorded 
by cause, by the year death occurred, and by the age, gender 
and ward of the deceased. The relative risks shown in Tables 
A2 and A3 apply only to persons aged over 35 and cannot 
refer to deaths occurring at earlier ages. Therefore counts 
of death were for those occurring at age 35 or over. This 
constraint means it is likely that we are underestimating both 
the number and proportion of total smoking-attributable 
mortality.
The death data were supplied by ONS with diseases coded 
according to the ICD-9 or ICD-10 international standards, 
depending on the year of the deaths concerned. Years 
1998–2000 applied the ICD-9 codes, while the ICD-10 codes 
were applied from 2001 onwards. No problems were notifi ed 
regarding bridging between ICD-9 and ICD-10. These codes 
are shown in Appendix 5. Counts at ward level ensured these 
data could then be aggregated to the level of the working 
target geography (PCT).
A note on timespans
Mortality information has been collected for a fi ve-year 
period (1998–2002). In the results sections the smoking-
attributable mortality counts have been divided by 5 to 
provide an annual average count for comparative purposes.
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Both models (Tables A4 and A5) had a binomial response 
variable and used a logit link function and second-order 
penalised quasi-likelihood for the estimation of the logit 
values. The model’s coeffi cients were checked for stability 
using Monte Carlo Markov Chain (MCMC) simulation 
(Rasbash et al., 2000; Browne, 2003). The resulting estimates 
from the MCMC current and past smoking models are 
presented below. The ecological variables for this model are 
defi ned as follows:
Appendix 2 Models of current and ex-smoking 
behaviour
Percentage of people in social grade A or B (SgAB)
Percentage of people in social grade C2, D or E (SgC2DE)
Percentage of people non-white (Ethnic)
Percentage of households with more than six rooms (Rooms)
Percentage of households in rented tenure (Rent)
Percentage of household with dependent children (DepenCh)
Percentage households with more than one car (Car1+)
Percentage of males economically inactive (Minactive)
Percentage of females unemployed (Funemp)
Percentage of households overcrowded (Overcrowding)
Table A6  Adjustments
Government regional offi ce
Current 
smoking 
model
Ex-smoking 
model
East Midlands  0.0081  0.0329
East of England  0.0104  0.0309
London  –0.0169  0.0184
North East  –0.0172  –0.0574
North West  0.0083  –0.0406
South East  0.0453  0.0378
South West  0.0014  –0.0127
West Midlands  –0.0387  –0.0389
Yorkshire and the Humber  –0.0016  0.0302
As part of the modelling process, residuals can be identifi ed 
at each level in the modelled hierarchy. As all regions are 
modelled, the region-level residual can be used to improve 
the estimations. These adjustments are shown in Table A6 
(the residuals are given as logits).
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Table A4  Current smoking model – mean estimates, standard deviation (SD) 
and credible interval1 results from fi nal MCMC model
Levels and variable 
type
Variable Coeffi cient (SD) 95% credible interval
Intercept –1.186 (0.038) –1.259 to –1.109
Individual terms: main 
effects
Single 0.748 (0.046) 0.658 to 0.842
Male 0.244 (0.044) 0.156 to 0.333
Age 16–24 0.470 (0.151) 0.177 to 0.750
Age 25–34 0.058 (0.038) –0.015 to 0.136
Age 45–54 0.018 (0.053) –0.086 to 0.116
Age 55–64 –0.231 (0.055) –0.337 to –0.122
Age 65–74 –0.579 (0.063) –0.701 to –0.458
Age 75+ –1.427 (0.077) –1.581 to –1.280
Individual terms: two-
way interactions
Single.Male –0.276 (0.060) –0.395 to –0.162
Single.16–24 –0.612 (0.153) –0.894 to –0.314
Single.45–54 –0.145 (0.083) –0.306 to 0.020
Single.55–75+ –0.359 (0.075) –0.501 to –0.206
Male.45–75+ –0.211 (0.062) –0.333 to –0.090
Individual term: three-
way interaction
Single.Male.45–75+ 0.378 (0.098) 0.187 to 0.574
Ecological effects: level 2 SgAB2 –0.017 (0.003) –0.023 to –0.010
Ethnic –0.012 (0.002) –0.015 to –0.009
Rooms –0.009 (0.002) –0.014 to –0.005
Rent 0.014 (0.002) 0.011 to 0.018
DepenCh 0.005 (0.003) –0.002 to 0.005
Minactive –0.001 (0.003) –0.007 to 0.005
Cross-level interactions 16–34.SgAB 0.009 (0.003) 0.004 to 0.015
Male.Ethnic 0.011 (0.002) 0.007 to 0.014
16–24.Ethnic –0.012 (0.003) –0.017 to –0.007
Single.Rent –0.005 (0.002) –0.008 to –0.001
55–75+.DepenCh 0.014 (0.006) 0.003 to 0.024
16–24.Minactive –0.012 (0.005) –0.023 to –0.002
1Credible intervals are derived via MCMC methods and can be interpreted in much the same way as 
traditional confi dence intervals.
2These are the two highest social grades in the current UK classifi cation.
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Table A5  Ex-smoking model – mean estimates, standard deviation (SD) and 
credible interval1 results from fi nal MCMC model
Levels and variable 
type
Variable Coeffi cient (SD) 95% credible interval
Intercept –1.134 (0.037) –1.207 to –1.058
Individual terms: main 
effects
Single –0.133 (0.037) –0.207 to –0.050
Male 0.094 (0.042) 0.012 to 0.175
Age 16–24 –0.211 (0.167) –0.543 to 0.092
Age 25–34 –0.155 (0.039) –0.230 to –0.081
Age 45–54 0.260 (0.048) 0.168 to 0.356
Age 55–64 0.461 (0.048) 0.364 to 0.555
Age 65–74 0.641 (0.053) 0.537 to 0.748
Age 75+ 0.815 (0.061) 0.694 to 0.934
Individual terms: two-
way interactions
Single.Male –0.215 (0.049) –0.312 to –0.122
Single.16–24 –0.513 (0.173) –0.83 to –0.540
Single.65–75+ 0.144 (0.057) 0.027 to 0.255
Male.45–54 0.336 (0.067) 0.203 to 0.461
Male.55–64 0.635 (0.067) 0.505 to 0.764
Male.65–74 0.818 (0.068) 0.688 to 0.955
Male.75+ 1.076 (0.081) 0.920 to 1.239
Ecological effects: level 2 SgC2DE –0.006 (0.002) –0.010 to –0.001
DepenCh –0.013 (0.004) –0.020 to –0.006
Car1+ 0.004 (0.002) 0.000 to 0.008
Overcrowding 0.016 (0.006) 0.005 to 0.028
Funemp –0.050 (0.023) –0.096 to –0.005
Ethnic –0.016 (0.002) –0.021 to –0.012
Cross-level interactions Single.SgC2DE –0.005 (0.002) –0.009 to –0.001
45–75+.SgC2DE 0.005 (0.002) 0.000 to 0.009
55–75+.DepenCh 0.019 (0.005) 0.010 to 0.029
55–75+.Cars1+ –0.007 (0.002) –0.011 to –0.003
Male.Overcrowded –0.015 (0.006) –0.027 to –0.002
16–34.Funemp 0.076 (0.030) 0.017 to 0.134
Single.Ethnic 0.006 (0.002) 0.002 to 0.010
Male.Ethnic 0.007 (0.003) 0.002 to 0.013
1Credible intervals are derived via MCMC methods and can be interpreted in much the same way as 
traditional confi dence intervals.
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How ‘good’ are the estimates? This is an important question, 
but in many ways it is not the right question. The real issue is 
the knowledge gain provided by the estimates: they provide 
a reasoned, localised insight into smoking and smoking-
attributable mortality. That insight has not previously been 
possible on the same basis across the whole of England.
Any evaluation of the estimates must recognise that they 
depend on two data sources: the HSfE and the 2001 Census. 
They also depend on the robustness of the two models and 
the reliability of the smoking-attributable risks. This multiple 
dependency means it is problematic to think in terms of 
traditional notions such as confi dence intervals around the 
estimates of smoking-attributable mortality. It is better to 
note that the data sources are the best available, while 
acknowledging that there is differential completion of HSfE 
questions and a level of non-response in the 2001 Census.
We can explore the quality question in two ways.
1. How good are the models used to estimate 
current smoking prevalence and the proportion of 
ex-smokers?
•  We can see how good the model is at predicting the 
original survey responses using the ‘Percentage Correct 
Prediction’ (Field, 2000). In the null current smoking 
model this is given as 50% and in the full model it rises to 
60.1%. For the ex-smoking models the values are 53.4% 
and 63.7%, respectively.
•  We can look at the deviance drop between the null 
and full models. The deviance statistic, given as –2* 
(loglikelihood), can be considered as a measure of 
poorness of fi t. By measuring the reduction in deviance 
in a full model from that in an initial (null) model, an 
assessment of model performance can be made. Table A7 
reports the deviance statistic for the initial null models and 
full models described in Appendix 2. The reduction in the 
value is given as a percentage of the null deviance.
•  The method described by Snijders and Bosker (1999) can 
be used to approximate the variance explained by the 
two models. In the model of current smoking behaviour 
this is estimated at 11.8%; for the ex-smoking model the 
corresponding value is 14%.
•  While we have noted above that it is problematic to 
generate confi dence intervals around our estimates of 
smoking-attributable mortality, we can use the approach 
described by Heady et al. (2003) to generate confi dence 
intervals around our estimates of smoking behaviour 
(Figures A1 and A2).
•  Goldstein (1995) outlines a method for apportioning the 
overall variance across the different levels of a multi-level 
model. The percentage of the level 2 area variance in the 
current smoking null model that is explained in the fi nal 
model is 68.2%. For current smoking approximately 5.4% 
of the overall variation in a null model is occurring at the 
level of postcode sector. Once the predictor variables are 
included, this is reduced to 0.5%. Overall this suggests 
that the model is relatively successful at controlling for 
variation at the postcode sector level – the level viewed 
as equivalent to wards for which current smoking is 
predicted. The percentage of level 2 area variance in the 
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Table A7 
Null model Full model Percentage 
reduction
Deviance statistic
Current smoking  51340.30  44166.54  14.0
Ex-smoking  56300.23  46951.68  16.6
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between the synthetic and direct estimates is above 5% in 
only three of the SHAs; in half, the difference is less than 
1%.
•  In comparing the synthetic estimates with those derived 
directly from the HSfE we are not necessarily assuming 
that one set is any more reliable than the other, but it 
must be noted that the HSfE was not originally designed 
to represent the SHA for the years reported in this 
comparative analysis.
2. How good are the relative risks for smoking-
attributable mortality?
We use the published relative risks employed by Callum 
(1998). These are taken from the US DHHS (1989) and are 
widely used in other studies. They continue to represent the 
best available information on attributable risk, but it must 
be noted that there are confi dence intervals associated with 
these measures (Table A8).
ex-smoking model that is explained in the fi nal model is 
40.6%. Approximately 2.0% of the overall variation in 
a null model is occurring at the level of postcode sector. 
Once the predictor variables are included, this is reduced 
to 1.2%.
•  Direct survey estimates can be compared with the 
synthetic modelled estimates using simple scatter plots 
and correlations (Twigg and Moon, 2002). Estimates of 
current smoking behaviour for SHAs have recently been 
generated from the HSfE by merging several years of 
survey results. Figure A3 shows the relationship between 
the synthetic estimates used in this report and estimated 
prevalences produced directly from the HSfE for all 
persons. The synthetic estimates are based on four runs 
of HSfE information (1998–2001) and the direct estimates 
relate to the average for 1998–2000. The plot shows 
a positive association between the two sources with a 
correlation coeffi cient of 0.485 (P = 0.009). The difference 
Figure A1  Model estimates and 95% confi dence 
intervals for current smoking
Figure A2  Model estimates and 95% confi dence 
intervals for ex-smoking
Figure A3  Direct versus synthetic estimates: smoking 
prevalences (persons)
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Table A8
Disease
Male smokers Female smokers
Current
(rc)
Ex
(rf)
Current
(rc)
Ex
(rf)
Cancers
 Lung 26.6 (21.0–33.6) 8.2 (6.5–10.4) 13.6 (11.6–16.0) 4.1 (3.4–4.9)
 Upper respiratory sites 10.6 (6.0–18.7) 3.0 (1.6 –5.5) 6.1 (3.8–10.0) 1.5 (0.8–2.9)
 Oesophagus 5.3 (3.1–9.2) 4.0 (2.3–6.9) 9.3 (4.7–18.3) 3.1 (1.4–6.7)
 Bladder 2.9 (1.9–4.4) 2.1 (1.4–3.0) 1.6 (0.8–3.0) 1.5 (0.8–2.7)
 Kidney 2.8 (1.9–4.2) 1.6 (1.1–2.4) 1.3 (0.9–2.0) 1.0 (0.6–1.6)
 Stomach 2.1 (1.4–3.2) 1.6 (1.1–2.3) 1.2 (0.8–1.8) 1.3 (0.9–2.0)
 Pancreas 2.2 (1.7–2.8) 1.1 (0.8–1.4) 2.3 (1.8–2.9) 1.5 (1.2–1.9)
 Unspecifi ed site 4.4 (3.3–5.9) 2.3 (1.8–3.1) 2.1 (1.7–2.6) 1.2 (0.9–1.6)
 Myeloid leukaemia 1.4 (0.8–2.3) 1.3 (0.8–2.0) 1.2 (0.7–2.0) 1.3 (0.8–2.0)
Respiratory
 Chronic obstructive lung disease 14.1 (10.3–19.3) 8.4 (6.4–11.2) 14.0 (10.9–18.1) 8.6 (6.7–11.0)
 Pneumonia 35–64 2.3 (1.2–4.4) 1.3 (1.1–1.6) 4.6 (2.4–8.6) 1.1 (0.8–1.5)
 Pneumonia 65+ 1.9 (1.4–2.6) 1.3 (1.1–1.6) 2.0 (1.4–2.7) 1.1 (0.8–1.5)
Circulatory
 Ischaemic heart disease 35–54 4.2 (3.1–5.7) 1.9 (1.3–2.6) 5.2 (3.3–8.3) 2.9 (1.7–5.0)
 Ischaemic heart disease 55–64 2.6 (2.2–3.0) 1.6 (1.4–1.9) 3.0 (2.5–3.7) 1.1 (0.9–1.5)
 Ischaemic heart disease 65–74 1.7 (1.6–1.9) 1.4 (1.2–1.5) 2.1 (1.8–2.4) 1.2 (1.0–1.4)
 Ischaemic heart disease 75+ 1.4 (1.2–1.6) 1.1 (1.0–1.2) 1.4 (1.3–1.7) 1.1 (1.0–1.2)
 Cerebrovascular disease 35–54 5.1 (2.1–12.2) 1.1 (0.7–1.7) 4.5 (2.4–8.5) 1.1 (0.7–1.7)
 Cerebrovascular disease 55–64 2.8 (1.9–4.3) 1.1 (0.7–1.7) 3.2 (2.2–4.7) 1.1 (0.7–1.7)
 Cerebrovascular disease 65–74 2.1 (1.6–2.7) 1.0 (0.9–1.2) 3.0 (2.4–3.9) 1.6 (1.2–2.1)
 Cerebrovascular disease 75+ 1.4 (1.1–1.8) 1.0 (0.9–1.2) 1.2 (1.0–1.6) 1.0 (0.8–1.3)
 Aortic aneurysm 5.3 (3.8–7.5) 2.6 (1.9–3.7) 8.2 (5.4–12.5) 1.6 (0.9–2.9)
 Myocardial degeneration 2.1 (1.8–2.4) 1.2 (1.1–1.4) 1.7 (1.5–2.0) 1.2 (1.0–1.4)
 Atherosclerosis 1.9 (1.0–3.4) 1.1 (0.7–1.9) 2.2 (1.2–4.0) 0.8 (0.4–1.7)
Digestive
 Stomach/duodenal ulcer 4.5 (1.9–10.3) 1.6 (0.7–3.2) 6.4 (3.3–12.4) 1.4 (0.6–3.5)
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Appendix 4 Census ward to census standard table 
ward lookup
Table A9
CAS ward Ward name
Standard 
table ward CAS ward Ward name
Standard 
table ward
00AAFE Bishopsgate 00AAFT 35UBGF Longhoughton with Craster 35UBGF 
00AAFS Farringdon Within 00AAFT 35UBGK Whittingham 35UBGK 
00AAFT Farringdon Without 00AAFT 35UCFS Bamburgh 35UCFU 
00AAFY Queenhithe 00AAFT 35UCFT Beadnell 35UCGE 
00AAFZ Tower 00AAFT 35UCFU Belford 35UCFU 
00AAGB Walbrook 00AAFT 35UCFW Cheviot 35UCFW 
15UHFB St Agnes 15UHFD 35UCFZ Flodden 35UCFW 
15UHFC St Martin’s 15UHFD 35UCGA Ford 35UCGC 
15UHFD St Mary’s 15UHFD 35UCGC Lowick 35UCGC 
15UHFE Tresco 15UHFD 35UCGE North Sunderland 35UCGE 
16UFGK Brough 16UFGK 35UCGF Prior 35UCGF 
16UFHH Ravenstonedale 16UFGK 35UCGH Shielfi eld 35UCGF 
20UHFY Barnard Castle West 20UHFY 35UFGK Acomb 35UFGK 
20UHFZ Barningham and Ovington 20UHGG 35UFGM Bellingham 35UFGM 
20UHGB Cotherstone with Lartington 20UHGC 35UFGN Broomhaugh and Riding 35UFHH 
20UHGC Eggleston 20UHGC 35UFGW Hexham Gilesgate 35UFGK 
20UHGF Gainford and Winston 20UHGF 35UFHG Redesdale 35UFHG 
20UHGG Greta 20UHGG 35UFHH Sandhoe with Dilston 35UFHH 
20UHGH Hamsterley and South 
Bedbu
20UHGK 35UFHM Upper North Tyne 35UFHG 
20UHGJ Ingleton 20UHGF 35UFHN Wanney 35UFGM 
20UHGK Lynesack 20UHGK 38UCFW Carfax 38UCFW 
20UHGL Middleton-in-Teesdale 20UHGL 38UCGD Holywell 38UCFW 
20UHGM Romaldkirk 20UHGL 39UFGM Chirbury 39UFHE 
20UHGN Staindrop 20UHGN 39UFGS Clun 39UFGS 
20UHGP Startforth 20UHFY 39UFGT Clun Forest 39UFGS 
20UHGQ Streatlam and Whorlton 20UHGN 39UFHE Worthen 39UFHE 
22UQGL Birchanger 22UQHB 40UFFY Aville Vale 40UFFY 
22UQHB Stansted South 22UQHB 40UFFZ Brompton Ralph and Haddon 40UFGB 
29UBHS Park Farm North 29UBHS 40UFGB Crowcombe and Stogumber 40UFGB 
29UBHT Park Farm South 29UBHS 40UFGD Dunster 40UFFY 
35UBGB Embleton 35UBGF 40UFGE Exmoor 40UFGL 
35UBGC Harbottle and Elsdon 35UBGK 40UFGL Quarme 40UFGL 
35UBGD Hedgeley 35UBGE 41UEGJ Keele 41UEGN 
35UBGE Longframlington 35UBGE 41UEGN Madeley 41UEGN 
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Appendix 5 Smoking-attributable diseases and 
their ICD-9 and ICD-10 codes
Table A10
Disease ICD-9 code ICD-10 code
Cancer
 Lung 162 C33 and C34
 Upper respiratory sites 161 and 1490 C32 and C140
 Oesophagus 150 C15
 Bladder 188 C67
 Kidney 1890 C64
 Stomach 151 C16
 Pancreas 157 C25
 Unspecifi ed site 1991 C80
 Myeloid leukaemia 205 C92
 Endometrial (uterus) 182 C54
Respiratory
 Chronic obstructive lung disease 496 J44
 Pneumonia 486 J18
Circulatory
 Ischaemic heart disease 410–414 I20–I25
 Cerebrovascular disease 430–438 I60–I69
 Aortic aneurysm 441 I71
 Myocardial degeneration 4291 I515
 Atherosclerosis 440 I70
Digestive
 Stomach/duodenal ulcer 531 and 532 K25 and K26
Parkinson’s disease 332 G20
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Appendix 6 Estimates of current smoking 
prevalence and proportion of ex-smokers: PCTs
Table A11
PCT code Name
Current smoking 
prevalence (%) Ex-smokers (%)
5L8 Adur, Arun and Worthing 26 36
5AW Airedale 24 32
5ED Amber Valley 27 32
5FA Ashfi eld 32 30
5LL Ashford 27 33
5HG Ashton, Leigh and Wigan 31 29
5C2 Barking and Dagenham 37 27
5A9 Barnet 25 28
5JE Barnsley 34 30
5GR Basildon 36 29
5ET Bassetlaw 29 31
5FL Bath and North East Somerset 25 32
5F8 Bebington and West Wirral 21 33
5GD Bedford 26 30
5GE Bedfordshire Heartlands 26 32
5FH Bexhill and Rother 22 38
TAK Bexley 27 30
5GP Billericay, Brentwood and Wickford 22 34
5H2 Birkenhead and Wallasey 31 28
5CC Blackburn with Darwen 29 25
5HP Blackpool 31 31
5G6 Blackwater Valley and Hart 26 32
5HQ Bolton 30 28
5CE Bournemouth Teaching 29 32
5G2 Bracknell Forest 27 31
5CF Bradford City 27 18
5CG Bradford South and West 31 28
5K5 Brent Teaching 27 22
5LQ Brighton and Hove City 33 32
5JF Bristol North 30 29
5JG Bristol South and West 33 29
5JL Broadland 23 34
5A7 Bromley 24 32
5EV Broxtowe & Hucknall 28 31
5G8 Burnley, Pendle and Rossendale 29 28
5DQ Burntwood, Lichfi eld and Tamworth 27 30
5JX Bury 28 29
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PCT code Name
Current smoking 
prevalence (%) Ex-smokers (%)
5J6 Calderdale 29 31
5JH Cambridge City 29 29
5K7 Camden 35 28
5MM Cannock Chase 29 29
5LM Canterbury and Coastal 27 33
5D4 Carlisle and District 29 30
5JP Castle Point and Rochford 24 34
5H4 Central Cheshire 26 30
5KT Central Cornwall 27 33
5AL Central Derby 32 23
5HA Central Liverpool 37 25
5CL Central Manchester 35 21
5JT Central Suffolk 23 34
5JC Charnwood and North West Leicestershire 26 31
5JN Chelmsford 25 33
5KW Cheltenham and Tewkesbury 26 32
5DV Cherwell Vale 26 33
5H3 Cheshire West 24 32
5EA Chesterfi eld 32 31
5G4 Chiltern and South Bucks 20 35
5F2 Chorley and South Ribble 26 30
5C3 City and Hackney Teaching 37 23
5GM Colchester 28 31
5KY Cotswold and Vale 24 33
5MD Coventry 29 26
5KJ Craven, Harrogate and Rural District 24 34
5MA Crawley 31 29
5K9 Croydon 26 26
5GW Dacorum 27 32
5J9 Darlington 29 29
5CM Dartford, Gravesham and Swanley 29 31
5AC Daventry and South Northamptonshire 23 33
5H7 Derbyshire Dales and South Derbyshire 25 32
5KA Derwentside 31 29
5CK Doncaster Central 32 29
5EK Doncaster East 28 31
5EL Doncaster West 34 29
5HV Dudley Beacon and Castle 31 27
5HT Dudley South 27 30
5KC Durham and Chester-le-Street 28 29
5J8 Durham Dales 30 30
5HX Ealing 27 25
5KD Easington 34 28
5JK East Cambridgeshire and Fenland 27 33
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PCT code Name
Current smoking 
prevalence (%) Ex-smokers (%)
5FT East Devon 22 36
5KP East Elmbridge and Mid Surrey 21 35
5FD East Hampshire 26 34
5LN East Kent Coastal 29 33
5HK East Leeds 34 29
5H9 East Lincolnshire 26 34
5ML East Staffordshire 25 30
5KQ East Surrey 24 34
5E3 East Yorkshire 23 33
5LR Eastbourne Downs 26 36
5MY Eastern Birmingham 32 25
5H5 Eastern Cheshire 22 33
5E5 Eastern Hull 40 27
5EY Eastern Leicester 28 21
5E7 Eastern Wakefi eld 35 30
5LY Eastleigh and Test Valley South 25 33
5D5 Eden Valley 25 33
5H6 Ellesmere Port and Neston 29 30
5C1 Enfi eld 28 27
5AJ Epping Forest 26 33
5ER Erewash 29 31
5FR Exeter 29 31
5LX Fareham and Gosport 26 33
5HE Fylde 22 34
5KF Gateshead 35 29
5EC Gedling 26 32
5GT Great Yarmouth 30 32
5EX Greater Derby 28 31
5A8 Greenwich 34 26
5L5 Guildford and Waverley 23 34
5J1 Halton 34 27
5KH Hambleton and Richmondshire 26 33
5H1 Hammersmith and Fulham 34 29
5C9 Haringey Teaching 32 24
5DC Harlow 36 30
5K6 Harrow 21 25
5D9 Hartlepool 33 28
5FJ Hastings and St Leonards 33 32
5A4 Havering 27 32
5MX Heart of Birmingham Teaching 28 15
5CN Herefordshire 25 32
5CP Hertsmere 26 32
5F4 Heywood and Middleton 35 28
5HN High Peak and Dales 25 34
5AT Hillingdon 27 28
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5JA Hinckley and Bosworth 25 32
5MC Horsham and Chanctonbury 23 35
5HY Hounslow 29 25
5LJ Huddersfi eld Central 28 28
5GF Huntingdonshire 25 32
5G7 Hyndburn and Ribble Valley 27 30
5JQ Ipswich 30 31
5DG Isle of Wight 27 34
5K8 Islington 38 26
5K4 Kennet and North Wiltshire 26 32
5LA Kensington and Chelsea 30 32
5A5 Kingston 25 30
5J4 Knowsley 36 26
5LD Lambeth 35 23
5KN Langbaurgh 29 29
5HJ Leeds North East 22 32
5HM Leeds North West 29 29
5HH Leeds West 33 29
5EJ Leicester City West 37 25
5LF Lewisham 33 24
5D3 Lincolnshire South West Teaching 26 32
5GC Luton 29 25
5L2 Maidstone Weald 26 33
5GL Maldon and South Chelmsford 23 33
5AM Mansfi eld District 32 30
5L3 Medway 30 29
5EH Melton, Rutland and Harborough 23 33
5FX Mendip 26 32
5E9 Mid-Hampshire 25 34
5FK Mid-Sussex 23 35
5FV Mid-Devon 26 33
5KM Middlesbrough 34 26
5CQ Milton Keynes 29 29
5DD Morecambe Bay 27 31
5A1 New Forest 23 36
5AP Newark and Sherwood 27 32
5DK Newbury and Community 26 33
5HW Newcastle-under-Lyme 28 30
5D7 Newcastle 33 27
5C5 Newham 33 18
5KR North and East Cornwall 26 33
5MW North Birmingham 24 30
5CH North Bradford 27 30
5FQ North Devon 26 33
5CD North Dorset 24 34
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PCT code Name
Current smoking 
prevalence (%) Ex-smokers (%)
5AN North East Lincolnshire 31 29
5DT North East Oxfordshire 26 32
5EG North Eastern Derbyshire 30 32
5DF North Hampshire 26 32
5GH North Hertfordshire and Stevenage 29 31
5J7 North Kirklees 29 27
5EF North Lincolnshire 29 31
5G9 North Liverpool 40 25
5CR North Manchester 40 25
5JM North Norfolk 25 36
5AF North Peterborough 31 28
5EE North Sheffi eld 38 27
5M8 North Somerset 23 34
5ME North Stoke 34 28
5L6 North Surrey 25 34
5E1 North Tees 29 28
5D8 North Tyneside 30 30
5MP North Warwickshire 28 29
5LW Northampton 28 29
5LV Northamptonshire Heartlands 29 30
TAC Northumberland Care Trust 28 31
5A2 Norwich 37 29
5EM Nottingham City 35 25
5MG Oldbury and Smethwick 29 23
5J5 Oldham 31 27
5DW Oxford City 29 29
5F1 Plymouth Teaching 32 30
5KV Poole 25 33
5FE Portsmouth City Teaching 33 29
5HD Preston 28 27
5DL Reading 28 30
5NA Redbridge 23 25
5MR Redditch and Bromsgrove 25 30
5M6 Richmond and Twickenham 24 32
5JY Rochdale 30 26
5H8 Rotherham 32 30
5MH Rowley Regis and Tipton 35 26
5GK Royston, Buntingford and Bishop’s Stortford 23 33
5M9 Rugby 24 30
5FC Rushcliffe 22 33
5F5 Salford 35 28
5KK Scarborough, Whitby and Ryedale 27 34
5KE Sedgefi eld 33 29
5E2 Selby and York 26 32
5EP Sheffi eld South West 24 31
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5EN Sheffi eld West 29 29
5LP Shepway 28 33
5M2 Shropshire County 25 32
5DM Slough 30 24
5D1 Solihull 23 31
5FW Somerset Coast 25 33
5FN South and East Dorset 22 37
5M1 South Birmingham 30 26
5JJ South Cambridgeshire 22 33
5GJ South East Hertfordshire 26 32
5DX South East Oxfordshire 22 35
5EQ South East Sheffi eld 35 29
5A3 South Gloucestershire 25 31
5CV South Hams and West Devon 23 34
5LK South Huddersfi eld 24 33
5HL South Leeds 34 29
5JD South Leicestershire 23 31
5HC South Liverpool 31 29
5AA South Manchester 37 26
5AG South Peterborough 27 31
5M5 South Sefton 31 29
5K1 South Somerset 25 33
5MF South Stoke 31 27
5KG South Tyneside 35 28
5MQ South Warwickshire 23 32
5FP South West Dorset 26 34
5FF South West Kent 24 35
5DY South West Oxfordshire 26 33
5MN South Western Staffordshire 23 32
5DJ South Wiltshire 27 33
5MT South Worcestershire 24 32
5L1 Southampton City 35 29
5AK Southend on Sea 28 33
5G1 Southern Norfolk 25 34
5F9 Southport and Formby 22 33
5LE Southwark 37 24
5J3 St Helens 32 29
5GX St Albans and Harpenden 22 33
5HR Staffordshire Moorlands 25 31
5F7 Stockport 26 31
5JR Suffolk Coastal 24 35
5JW Suffolk West 27 32
5KL Sunderland Teaching 35 27
5LT Sussex Downs and Weald 23 35
5M7 Sutton and Merton 27 29
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PCT code Name
Current smoking 
prevalence (%) Ex-smokers (%)
5L4 Swale 32 30
5K3 Swindon 29 30
5LH Tameside and Glossop 32 28
5K2 Taunton Deane 26 33
5FY Teignbridge 25 34
5MK Telford and Wrekin 29 27
5AH Tendring 25 36
5GQ Thurrock 33 29
5CW Torbay 28 33
5C4 Tower Hamlets 37 21
5F6 Trafford North 30 28
5CX Trafford South 23 32
5GN Uttlesford 22 34
5DP Vale of Aylesbury 25 32
5E8 Wakefi eld West 30 30
5M3 Walsall Teaching 30 27
5NC Waltham Forest 30 24
5LG Wandsworth 31 28
5J2 Warrington 27 30
5GV Watford and Three Rivers 26 31
5JV Waveney 27 33
5MJ Wednesbury and West Bromwich 31 25
5GG Welwyn Hatfi eld 28 32
5D6 West Cumbria 31 29
5KX West Gloucestershire 27 31
5E6 West Hull 38 27
5F3 West Lancashire 27 30
5D2 West Lincolnshire 28 32
5CY West Norfolk 26 34
5FM West of Cornwall 28 32
5DH West Wiltshire 25 32
5L9 Western Sussex 24 36
5LC Westminster 33 30
5G3 Windsor, Ascot and Maidenhead 23 33
TAG Witham, Braintree and Halstead 28 32
5L7 Woking Area 23 33
5DN Wokingham 20 32
5MV Wolverhampton City 30 25
5G5 Wycombe 25 31
5HF Wyre 24 33
5DR Wyre Forest 26 31
5E4 Yorkshire Wolds and Coast 25 33
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